Viking Therapeutics
VKTX
trading on NASDAQ
since 2015
Viking Therapeutics is a biopharmaceutical company focused on developing gene therapies to treat rare conditions such as lysosomal storage disorders and neurodegenerative diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $26.00 | $26.25 | $23.21 | $4.50B | 64.60M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.58 | n/a | +Inf | -Inf% | -Inf% | 0% |